Tech Investment

Business

Therapeutics Sector Shows Resilience in Q3: United Therapeutics Lags as Halozyme and Biogen Outperform

A mixed third-quarter earnings season for therapeutics stocks reveals divergent paths, with United Therapeutics missing estimates while peers like Halozyme and Biogen post strong beats. Sector-wide revenue growth and positive stock reactions suggest underlying investor confidence despite regulatory and pricing headwinds.

Jan 30, 2026

World

Iran Draws Red Line on Missile Program as U.S. Naval Buildup Intensifies

Amid escalating tensions and a U.S. military buildup in the Gulf, Iran's foreign minister has declared the country's missile capabilities 'non-negotiable,' setting the stage for a precarious diplomatic standoff.

Jan 30, 2026

World

Newly Released Epstein Documents Contain Unverified Claims About Bill Gates and Other High-Profile Figures

A trove of documents released by the U.S. Department of Justice includes emails from Jeffrey Epstein making lurid, unsubstantiated allegations about Bill Gates, while also detailing his interactions with other prominent individuals.

Jan 30, 2026

World

Poland Points Finger at Russian Spy Agency Over Destructive Year-End Cyberattacks on Critical Infrastructure

Polish cybersecurity authorities have attributed a wave of disruptive cyberattacks in late December to a hacking group linked to Russia's FSB, marking a potential escalation in tactics against energy and heating infrastructure during a severe winter storm.

Jan 30, 2026

Business

Haemonetics Gains Analyst Backing After Strategic Vivasure Buyout

Haemonetics (NYSE:HAE) sees its price target raised by Barrington Research following its acquisition of Vivasure Medical, with analysts highlighting the deal's potential to bolster its medical device portfolio and drive growth.

Jan 30, 2026

Business

U.S. Drilling Activity Stalls Amid Mixed Signals for Oil and Gas

The U.S. rig count saw a marginal increase this week, yet remains significantly below last year's levels as crude production dips and completions activity sends conflicting signals.

Jan 30, 2026

Business

Campbell's to Close Historic Cape Cod Chip Plant, Ending a Local Era

Campbell Soup Company will shutter its Hyannis, Massachusetts facility, the original home of Cape Cod Potato Chips, citing economic inefficiency. The closure, affecting 49 jobs, marks a strategic shift of production to larger plants as the snack giant consolidates its network.

Jan 30, 2026

Business

Oshkosh Navigates Tariff Headwinds and Mixed Demand to Set 2026 Course

Oshkosh Corporation topped revenue expectations in its latest quarter, but profit fell short as tariffs and cost pressures squeezed margins. The specialty vehicle maker's 2026 outlook balances targeted growth in some segments against persistent challenges in construction markets.

Jan 30, 2026

Business

Thermo Fisher Beats Q4 Estimates on Product Launches, Acquisitions; Shares Dip Amid Broader Concerns

Thermo Fisher Scientific posted stronger-than-expected Q4 revenue and profit, driven by new products and strategic deals. However, the stock fell as investors weighed pressures in key academic and government markets against the company's solid 2026 outlook.

Jan 30, 2026

Business

Three Mid-Cap Stocks Facing Headwinds: Why Analysts Are Sounding the Alarm

While mid-cap companies often represent a sweet spot between growth and stability, heightened competition and shifting market dynamics are putting pressure on some notable names. Here’s a closer look at three stocks where caution may be warranted.

Jan 30, 2026

Business

Navigating the Giants: One Large-Cap Stock with Room to Run, and Two Facing Headwinds

While large-cap stocks offer stability, their massive scale often limits growth. We analyze three market leaders, identifying one with compelling potential and two where the current story may be fully priced in.

Jan 30, 2026

Business

Value Traps: Three 'Bargain' Stocks That May Not Be Worth the Risk

While the allure of finding the next undervalued gem is strong, some stocks trading at low multiples may be cheap for a reason. We examine three companies where fundamental challenges could outweigh their seemingly attractive valuations.

Jan 30, 2026

Business

Mixed Fortunes for Banking Giants: Citigroup Lags as Peers Navigate Q4 Headwinds

The fourth-quarter earnings season for diversified banks revealed a tale of divergence. While PNC Financial surprised to the upside, industry titan Citigroup fell short of expectations, highlighting the uneven pressures facing the sector.

Jan 30, 2026

Business

Sales & Marketing Software Sector's Q3: Strong Results Meet Skeptical Market

While the sales and marketing software segment broadly exceeded revenue expectations in Q3, investor sentiment has turned sour, with most stocks falling post-earnings. We analyze the divergent performances of Upland Software, Sprinklr, DoubleVerify, PubMatic, and Sprout Social.

Jan 30, 2026

Business

Q3 Earnings Spotlight: How WillScot Mobile Mini Stacks Up Against Construction Services Peers

As earnings season concludes, we analyze the performance of construction and maintenance services stocks. While the sector showed overall strength, WillScot Mobile Mini faced headwinds, contrasting with standout results from peers like Comfort Systems.

Jan 30, 2026

Business

Beyond the Bottom Line: How Waste Management Giants Fared in Q3 Amid Economic Crosswinds

As earnings season winds down, the waste management sector reveals a tale of resilience and regulatory reckoning. While Enviri's results disappointed, others like Perma-Fix surprised to the upside, highlighting the industry's complex dance between steady demand and economic sensitivity.

Jan 30, 2026

Business

DexCom's Strong Q4 Preliminary Results and Ambitious 2026 Outlook Fuel Investor Optimism

DexCom Inc. (DXCM) has released preliminary Q4 figures that exceeded expectations and provided robust long-term guidance, reinforcing its position as a favored pick among analysts and hedge funds in the medical devices sector.

Jan 30, 2026

Business

Edwards Lifesciences Gains Analyst Favor as Renewed Growth Cycle Takes Hold

Wall Street analysts are raising price targets on Edwards Lifesciences, citing a renewed growth cycle driven by TAVR expansion and a strong product pipeline, positioning the medical device maker as a favored pick.

Jan 30, 2026

Business

Medtronic's Growth Outlook Tempered by Survey on Renal Denervation Adoption

A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.

Jan 30, 2026

Business

Visa, Mastercard Remain Skeptical of Stablecoins for Mainstream Payments, Despite Crypto's Promise

The world's largest payment networks are taking a measured approach to stablecoins for everyday consumer transactions, citing a lack of clear demand in developed markets and emphasizing their role as infrastructure providers rather than disruptors.

Jan 30, 2026